We are delighted to announce Anemocyte’s participation in BioJapan / Regenerative Medicine Japan / healthTECH Japan 2025, taking place from October 8–10, 2025 at PACIFICO Yokohama.
This leading partnering event in Asia brings together global innovators, research institutions, pharmaceutical companies, and biotech players to explore breakthroughs across biotechnology, regenerative medicine, and digital health.
The three concurrent exhibitions—BioJapan, Regenerative Medicine Japan, and healthTECH Japan—form a comprehensive platform where science, technology, and industry converge. With thousands of one-to-one partnering meetings and a rich program of seminars, the event is designed to accelerate collaborations and shape the future of healthcare worldwide.
For Anemocyte, this is a unique opportunity to present our expertise in pDNA and mRNA manufacturing, share our commitment to innovation in advanced therapies, and strengthen ties with partners across Asia and beyond.
We look forward to engaging in meaningful conversations in Yokohama and contributing to the dialogue that will define the future of biotech and regenerative medicine.
